X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (533) 533
male (306) 306
index medicus (300) 300
female (297) 297
roseolovirus infections - virology (246) 246
adult (245) 245
immunology (223) 223
herpesvirus 6, human - isolation & purification (192) 192
middle aged (180) 180
transplantation (164) 164
herpesvirus 6, human - genetics (162) 162
roseolovirus infections - complications (154) 154
roseolovirus infections - immunology (148) 148
infection (145) 145
roseolovirus infections - diagnosis (144) 144
virology (144) 144
herpesvirus 6, human - immunology (134) 134
adolescent (130) 130
hhv-6 (130) 130
infectious diseases (118) 118
polymerase chain reaction (117) 117
human herpesvirus 6 (113) 113
dna (104) 104
child (100) 100
viral load (95) 95
health aspects (92) 92
roseolovirus infections - epidemiology (92) 92
child, preschool (89) 89
infant (89) 89
aged (88) 88
dna, viral - blood (86) 86
herpesvirus 6, human - physiology (86) 86
human herpesvirus-6 (85) 85
human-herpesvirus-6 (85) 85
viruses (85) 85
encephalitis (80) 80
antibodies, viral - blood (76) 76
virus diseases (74) 74
young adult (74) 74
herpesvirus 6, human (73) 73
microbiology (71) 71
recipients (69) 69
virus (69) 69
polymerase-chain-reaction (67) 67
infections (66) 66
children (65) 65
hematology (65) 65
cytomegalovirus (63) 63
reactivation (63) 63
risk factors (63) 63
dna, viral - analysis (59) 59
antiviral agents - therapeutic use (58) 58
roseolovirus infections - drug therapy (58) 58
herpesvirus 6, human - pathogenicity (57) 57
virus activation (56) 56
allergy and immunology (53) 53
bone-marrow-transplantation (53) 53
human-herpesvirus-6 infection (53) 53
infectious disease (53) 53
stem-cell transplantation (53) 53
hematopoietic stem cells (49) 49
roseolovirus infections - etiology (49) 49
surgery (49) 49
dna, viral - genetics (48) 48
hematopoietic stem cell transplantation - adverse effects (48) 48
herpesvirus 7, human - isolation & purification (48) 48
roseolovirus infections - pathology (48) 48
disease (46) 46
analysis (44) 44
human-herpesvirus 6 (44) 44
blood (43) 43
diagnosis (43) 43
oncology (43) 43
research (43) 43
stem cells (43) 43
exanthem-subitum (41) 41
multiple sclerosis (41) 41
roseolovirus infections - blood (41) 41
treatment outcome (41) 41
herpes (40) 40
herpesvirus 7, human - genetics (40) 40
prevalence (40) 40
retrospective studies (39) 39
transplantation, homologous (39) 39
herpesvirus diseases (38) 38
animals (37) 37
cerebrospinal-fluid (35) 35
ganciclovir (35) 35
association (34) 34
epstein-barr-virus (34) 34
immunoglobulin g - blood (33) 33
pediatrics (33) 33
care and treatment (32) 32
multiple sclerosis - virology (32) 32
hematopoietic stem cell transplantation (31) 31
herpesvirus 7, human - immunology (31) 31
identification (31) 31
prospective studies (31) 31
human herpesvirus-6 infection (30) 30
incidence (29) 29
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (530) 530
Japanese (6) 6
Chinese (5) 5
Russian (5) 5
Hungarian (3) 3
Turkish (2) 2
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Liver International, ISSN 1478-3223, 02/2018, Volume 38, Issue 2, pp. 210 - 223
Human herpesvirus 6 (HHV‐6A and HHV‐6B) can cause primary infection or reactivate from latency in liver transplant recipients, which can result in a variety of... 
chromosomally integrated HHV‐6 (CIHHV‐6) | liver transplantation | human herpesvirus 6 (HHV‐6) | human herpesvirus 6 (HHV-6) | chromosomally integrated HHV-6 (CIHHV-6) | INTEGRATED HUMAN HERPESVIRUS-6 | HUMAN-HERPESVIRUS 6 | SOLID-ORGAN | RECIPIENTS | CYTOMEGALOVIRUS | PRIMARY HUMAN-HERPESVIRUS-6 INFECTION | POLYMERASE-CHAIN-REACTION | HEPATITIS-C VIRUS | DONOR BIOPSIES | GASTROENTEROLOGY & HEPATOLOGY | CLINICAL-SIGNIFICANCE | Herpesvirus 6, Human - drug effects | Opportunistic Infections - virology | Liver Transplantation - adverse effects | Antiviral Agents - therapeutic use | Humans | Risk Factors | Roseolovirus Infections - diagnosis | Graft Survival | Roseolovirus Infections - immunology | Treatment Outcome | Graft Rejection - virology | Opportunistic Infections - diagnosis | Roseolovirus Infections - drug therapy | Herpesvirus 6, Human - immunology | Herpesvirus 6, Human - pathogenicity | Virus Activation - drug effects | Antiviral Agents - adverse effects | Opportunistic Infections - drug therapy | Immunosuppressive Agents - adverse effects | Roseolovirus Infections - virology | Opportunistic Infections - immunology | Graft Rejection - immunology | Immunocompromised Host | Liver | Organ transplant recipients | Cytomegalovirus infections | Development and progression | Transplantation | Hepatitis C | Risk factors | Transplants & implants | Pathogenesis | Opportunist infection | Infections | Activation | Blood | Literature reviews | Hepatitis | Ganciclovir | Allografts | Diagnosis | Deoxyribonucleic acid--DNA | Encephalitis | Health risks | Cidofovir | Risk analysis | Fever | Graft rejection | Latency | Foscarnet | Biopsy | Fibrosis | Hepatitis C virus | Liver transplantation
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 11, pp. 2017 - 2022
Abstract Human herpesvirus-6 (HHV-6) is known to reactivate after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and may be associated with... 
Hematology, Oncology and Palliative Medicine | Human herpesvirus-6 | Allogeneic hematopoietic stem cell transplantation | HHV-6 REACTIVATION | BONE-MARROW-TRANSPLANTATION | PREEMPTIVE THERAPY | HUMAN-HERPESVIRUS-6 REACTIVATION | IMMUNOLOGY | VERSUS-HOST-DISEASE | CONDITIONING REGIMEN | TRANSPLANTATION | PLASMA | ENCEPHALITIS | 6 INFECTION | HEMATOLOGY | BLOOD | Graft vs Host Disease - therapy | Recurrence | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Myeloablative Agonists - adverse effects | Humans | Middle Aged | Roseolovirus Infections - therapy | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Leukemia, Myeloid, Acute - immunology | Graft vs Host Disease - immunology | Transplantation, Homologous | Herpesvirus 6, Human - immunology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Graft vs Host Disease - mortality | Adult | Female | Retrospective Studies | Transplantation Conditioning - methods | Leukemia, Myeloid, Acute - therapy | Hematopoietic Stem Cell Transplantation | Roseolovirus Infections - immunology | Roseolovirus Infections - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Leukemia, Myeloid, Acute - diagnosis | Adolescent | Survival Analysis | Roseolovirus Infections - virology | Aged | Tissue Donors | Virus Activation - immunology | Cytomegalovirus infections | Transplantation | Analysis | Mortality | Hematopoietic stem cells | Stem cells
Journal Article
Journal Article